rofecoxib has been researched along with Ovarian Neoplasms in 1 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakubowska-Mućka, A | 1 |
| Sieńko, J | 1 |
| Switaj, T | 1 |
| Gołab, J | 1 |
| Lasek, W | 1 |
1 other study available for rofecoxib and Ovarian Neoplasms
| Article | Year |
|---|---|
[Antitumor effects of sulindac in ovarian cell cultures].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Cell Cycle; Cell Size; Cell | 2011 |